insights_auto
Why is 000739 down 8.69%?
Dive Deeperchevron_right
000739:SHE
Apeloa Pharmaceutical Co Ltd
CN¥24.89
arrow_downward
-8.69%(-2.37) 1D
Oct 9, 1:21:33 PM GMT+8 · CNY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 000739...
Open
CN¥26.88
High
CN¥27.17
Low
CN¥24.53
Mkt. cap
32.14B
Avg. vol.
18.93M
Volume
23.23M
Dividend
1.51%
Quarterly dividend
CN¥0.09
Ex-dividend date
Apr 29, 2026
P/E ratio
33.78
52-wk high
CN¥28.50
52-wk low
CN¥14.89
EPS
CN¥0.74
Shares outstanding
1.16B
No. of employees
7K
Open
CN¥26.88
High
CN¥27.17
Low
CN¥24.53
Mkt. cap
32.14B
Avg. vol.
18.93M
Volume
23.23M
Dividend
1.51%
Quarterly dividend
CN¥0.09
Ex-dividend date
Apr 29, 2026
P/E ratio
33.78
52-wk high
CN¥28.50
52-wk low
CN¥14.89
EPS
CN¥0.74
Shares outstanding
1.16B
No. of employees
7K
News stories
From web sources and news partners
Insurance Journal
·
15 minutes ago
AI Bubble Risks Worst S&P 500 Crash Since 2008, Strategist Says
24/7 Wall St.
·
8 hours ago
XLG Cuts the S&P 500 Down to 50 Stocks. The Result Is an Index Fund Built Entirely Around Mega-Caps
ChartMill
·
10 hours ago
Top S&P500 movers in Thursday's session
Action Forex
·
2 hours ago
S&P 500 Wave Analysis
Profile
Apeloa Pharmaceutical Co., Ltd., known as Apeloa, is a Chinese pharmaceutical manufacturer under Hengdian Group. The company is headquartered in Hengdian, Dongyang, Zhejiang, China. It was founded in 1989 and has been listed on the Shenzhen Stock Exchange since 9 May 1997. Apeloa provides contract development and manufacturing services and manufactures APIs and finished dosage forms; products span cardiovascular, anti-infective, psychiatric and oncology areas.
Apeloa has 7400 employees, 8 manufacturing sites and 3 R&D centers in Boston, Shanghai and Hengdian, covering flow chemistry, synthetic biology and biocatalysis, and peptide development. It has invested over USD20 million in flow chemistry over the past ten years in an effort to advance sustainable pharmaceutical manufacturing. In Boston, its 17,000-square-foot facility does R&D related to chemistry needs in drug development, including preclinical chemistry, scale-up production and new drug development.
Apeloa Pharmaceutical has successfully passed 20 U.S. FDA inspections since 2006. Wikipedia
About Apeloa Pharmaceutical Co Ltd